Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. europe
  4. invasive breast cancer
Show results for
Products

Companies


Refine by
Locations
Back to All Locations

  • Europe
  • Albania
  • Andorra
  • Austria
  • Belarus
  • Belgium
  • Bosnia & Herzegovina
  • Bulgaria
  • Croatia
  • Cyprus
  • Czech Republic
  • Denmark
  • Estonia
  • Faroe Islands
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Kosovo
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macedonia
  • Malta
  • Moldova
  • Monaco
  • Montenegro
  • Netherlands
  • Northern Ireland
  • Norway
  • Poland
  • Portugal
  • Romania
  • San Marino
  • Serbia
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • Ukraine
  • United Kingdom
  • Vatican City
Brands

  • mammatyper
  • sagasafe
  • virasoft

Invasive Breast Cancer Equipment Supplied In Europe

3 equipment items found
In EuropeAvailable In EuropeNear Europe

MammaTyper - Model PgR - Progesterone Receptor (PGR) Biomarker

MammaTyper - Model PgR - Progesterone Receptor (PGR) Biomarker

Manufactured by:Cerca Biotech   based inBerlin, GERMANY
Upon binding of progesterone, the receptor is activated and modifies expression of several downstream genes. Estrogen and progesterone receptors are found in Breast Cancer cells that depend on estrogen and related hormones (such as progesterone) to grow. All patients with invasive Breast Cancer or a ...
CONTACT SUPPLIER

Virasoft - Model HER2 - Epidermal Growth Factor Receptor 2

Virasoft - Model HER2 - Epidermal Growth Factor Receptor 2

Manufactured by:Virasoft Inc.   based inSarıyer, TURKEY
Amplification of the HER2 gene and overexpression of HER2 receptor on the cell membrane is observed in approximately %15 of invasive breast ...
CONTACT SUPPLIER

SAGAsafe - Model ESR1 - Diagnostic Assays

SAGAsafe - Model ESR1 - Diagnostic Assays

Manufactured by:SAGA Diagnostics AB   based inLund, SWEDEN
ESR1 mutations are found in primary breast cancers prior to therapy initiation and are associated to worse relapse-free and overall survival. These results were reported today by a group of researchers from Lund University and Skåne University Hospital in a new studied published in JNCI Cancer ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT